Accelerate your product development and approvals by providing the information necessary for predictive clinical outcomes and bioequivalence.
Our new INVIDA™ Platform lets you measure the aerosol dispersion and regional deposition of inhaled drugs under human-realistic breathing profiles. A valuable tool for understanding your product’s in vivo performance, the innovative technology gives you a visual map of your product within the respiratory tract, as well as quantitative measurements of drug deposition. Applications include:
- Predictive Clinical Assessment
- Bioequivalence – IVIVC Studies
- Dispersion & Deposition Studies
- Formulation Characterization & Screening
- Uniformity of Delivered Dose
- Uniformity of Delivered Mass
- Inter-/intra-container Through-life Product Testing
- Aerodynamic Assessment of Nebulized Aerosols
- Particle Flight - Dispersion - Deposition Characterization
- Device Characterization, Design & Screening
- Peak Inspiratory Flow Studies
- Total Delivered Dose Content
- Device Resistance Characterization